M. Araz Et Al. , "Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6, pp.1091-1097, 2019
Araz, M. Et Al. 2019. Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6 , 1091-1097.
Araz, M., Karaagac, M., Korkmaz, L., KORAL, L., İNCİ, F., Beypinar, I., ... Uysal, M.(2019). Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6, 1091-1097.
Araz, Murat Et Al. "Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6, 1091-1097, 2019
Araz, Murat Et Al. "Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6, pp.1091-1097, 2019
Araz, M. Et Al. (2019) . "Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.83, no.6, pp.1091-1097.
@article{article, author={Murat Araz Et Al. }, title={Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study}, journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY}, year=2019, pages={1091-1097} }